Finch Therapeutics Group, Inc. (FNCHQ)
Finch Therapeutics Group, Inc. engages in the development of microbiome drugs. Its platform includes Human-First Discovery that enables reverse translation from clinical data to engineer the composition of the microbiome based on disease-modifying mechanisms. The company was founded by Mark Smith, Andrew Noh, Tom Borody and Zain Kassam in 2014 and is headquartered in Boston, MA.
Sector: Biological Products, (No Diagnostic Substances)
Industry: Biotechnology
Finch Therapeutics Group, Inc.
OTC:FNCHQHealthcare · Biotechnology
Mkt Cap$16.62M
Float759K
O/S1.61M
Inst Own-
SI0.1%
Dilution
Delisting Issues Timeline
Financials Summary
Revenue$0
Net Income-$13.88M
Total Assets$49.75M
Free Cash Flow-$31.5M
Debt & Equity
Debt 75%
Equity 25%
Total Debt$27.79M
Total Equity$9.08M
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in FNCHQ's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$49.75M
Liabilities$40.67M
Accounts Receivable$0
Accounts Payable$148K
Inventory$0
PP&E (Net)$24.67M
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD |
| Period Ending | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Revenue | $0 | $107K | $861K | $18.53M | $7.72M | $10.15M |
| YoY Growth | - | -87.6% | -95.4% | 140.1% | -24.0% | - |
| Cost of Revenue | $174K | $1.52M | $5.51M | $57.28M | $33.14M | $314K |
| Gross Profit | -$174K | -$1.41M | -$4.65M | -$38.75M | -$25.43M | $9.84M |
| Gross Margin | - | -1320.6% | -539.6% | -209.1% | -329.4% | 96.9% |
| Research and Development | $0 | $7.2M | $52.86M | $57.28M | $33.14M | $23.54M |
| Selling, General, and Administrative | $18.68M | $26.91M | $36.19M | $21.24M | $14.01M | $7.44M |
| Other | $0 | -$1.52M | $1.42M | $0 | $0 | $0 |
| Total Operating Expenses | $18.68M | $32.59M | $90.47M | $78.52M | $47.16M | $30.98M |
| Operating Income (EBIT) | -$18.86M | -$34M | -$95.12M | -$59.98M | -$39.44M | -$21.14M |
| Operating Margin | - | -31777.6% | -11047.6% | -323.7% | -510.9% | -208.2% |
| Interest Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Interest Income | $796K | $1.57M | $252K | $22K | $106K | $488K |
| Other Income (Expense) | $4.98M | -$44.21M | -$19.53M | $1.82M | $95K | $388K |
| Income Before Tax (EBT) | -$13.88M | -$78.22M | -$114.65M | -$58.16M | -$39.34M | -$20.75M |
| Income Tax Expense | $0 | -$3.46M | $0 | $0 | $0 | $0 |
| Net Income | -$13.88M | -$74.75M | -$114.65M | -$58.16M | -$39.25M | -$20.75M |
| Net Income Margin | - | -69863.6% | -13315.4% | -313.8% | -508.5% | -204.4% |
| Supplementary Data | ||||||
| EPS | -8.64 | -46.59 | -72.12 | -36.72 | -24.39 | -12.68 |
| Diluted EPS | -8.64 | -46.59 | -72.12 | -36.72 | -24.39 | -12.68 |
| Weighted Average OS | 1.61M | 1.60M | 1.59M | 1.58M | 1.61M | 1.61M |
| EBITDA | -$13.7M | -$32.48M | -$82.69M | -$57.68M | -$38.65M | -$20.66M |
| EBITDA Margin | - | -30357.0% | -9603.6% | -311.3% | -500.7% | -203.5% |
Balance Sheet
| Period | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD |
| Period Ending | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Assets | ||||||
| Current Assets | ||||||
| Cash and Cash Equivalents | $10.26M | $25.12M | $71.04M | $133.48M | $99.71M | $42.19M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $10.26M | $25.12M | $71.04M | $133.48M | $99.71M | $42.19M |
| Accounts Receivable | $0 | $0 | $144K | $494K | $1.09M | $4.75M |
| Inventory | $0 | $0 | -$3.51M | -$9.07M | $0 | $0 |
| Other Current Assets | $504K | $723K | $3.37M | $9.07M | $0 | $0 |
| Total Current Assets | $10.77M | $25.85M | $71.04M | $142.55M | $106.16M | $48.63M |
| Long-Term Assets | ||||||
| Property, Plant & Equipment Net | $24.67M | $27.18M | $48.69M | $24.69M | $7M | $3.78M |
| Goodwill | $0 | $0 | $0 | $18.06M | $18.06M | $18.06M |
| Intangible Assets | $0 | $0 | $32.9M | $32.9M | $32.9M | $32.9M |
| Long-Term Investments | $2.35M | $2.35M | $2.57M | $2.27M | $200K | $210K |
| Deferred Tax Assets | $11.97M | $0 | $13.64M | $6.76M | $4.72M | $4.69M |
| Other Long-Term Assets | $0 | $0 | -$5.89M | $7.22M | -$3.71M | -$4.69M |
| Total Long-Term Assets | $38.98M | $29.53M | $91.9M | $91.89M | $59.17M | $54.94M |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $49.75M | $55.37M | $162.94M | $225.37M | $165.34M | $103.57M |
| Liabilities | ||||||
| Current Liabilities | ||||||
| Accounts Payable | $148K | $141K | $1.1M | $3.74M | $2.62M | $655K |
| Short-Term Debt | $2.26M | $0 | $0 | $0 | $0 | $0 |
| Current Income Tax Payable | $0 | $418K | $868K | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $3.37M | $2.38M |
| Other Current Liabilities | $572K | $125K | $680K | $4.4M | $3.53M | $2.19M |
| Total Current Liabilities | $3.17M | $4.08M | $14.69M | $14.79M | $11.49M | $7.33M |
| Long-Term Liabilities | ||||||
| Long-Term Debt | $0 | $0 | $14.65M | $4.89M | $1.81M | $143.15M |
| Long-Term Unearned Revenue | $0 | -$28.4M | $0 | -$8.35M | $10.26M | $8.29M |
| Long-Term Deferred Tax Liabilities | $11.97M | $15.62M | $3.46M | $10.22M | $3.46M | $3.46M |
| Other Long-Term Liabilities | $0 | $0 | $170K | $7K | $234.04M | $879K |
| Total Long-Term Liabilities | $37.5M | $28.4M | $52.54M | $8.36M | $249.57M | $155.78M |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $40.67M | $32.49M | $67.23M | $23.14M | $261.06M | $163.1M |
| Stockholders' Equity | ||||||
| Preferred Stock | $0 | $0 | $0 | $225.37M | $233.05M | $143.15M |
| Common Stock | $2K | $2K | $48K | $47K | $8K | $8K |
| Retained Earnings | -$364.27M | -$350.39M | -$275.64M | -$161M | -$102.83M | -$63.49M |
| Comprehensive Income & Other | $0 | $0 | $0 | -$225.37M | -$233.05M | -$143.15M |
| Other Stockholders' Equity | $373.35M | $373.28M | $371.3M | $363.17M | $7.11M | $3.95M |
| Total Equity | $9.08M | $22.89M | $95.71M | $202.22M | -$95.72M | -$59.53M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $49.75M | $55.37M | $162.94M | $225.37M | $165.34M | $103.57M |
| Supplementary Data | ||||||
| Total Debt | $27.79M | $30.13M | $52.34M | $10.91M | $1.81M | $143.15M |
| Net Debt | $17.53M | $5M | -$18.7M | -$122.57M | -$97.9M | $100.96M |
Cash Flow Statement
| Period | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD |
| Period Ending | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Operating Activities | |||||
| Net Income | -$74.75M | -$114.65M | -$58.16M | -$39.34M | -$20.75M |
| Depreciation & Amortization | $1.52M | $5.51M | $2.3M | $790K | $482K |
| Deferred Income Tax | -$3.46M | $0 | -$1.84M | $0 | $0 |
| Stock-Based Compensation | $1.93M | $7.84M | $4.16M | $3.1M | $606K |
| Changes in Working Capital: | |||||
| Accounts Receivable | $143K | $350K | $540K | $143K | $1.2M |
| Inventory | $0 | $0 | -$3.68M | $255K | $43K |
| Accounts Payable | -$956K | -$2.26M | $2.26M | $440K | -$1.06M |
| Other Working Capital | -$4.61M | $345K | -$13.63M | $20K | $2.02M |
| Total Working Capital Change | -$5.42M | -$1.56M | -$14.51M | $4.11M | $2.21M |
| Other Non-Cash Items | $48.68M | $28.01M | $913K | $13K | $140K |
| Net Cash from Operating | -$31.5M | -$74.85M | -$67.13M | -$31.33M | -$17.32M |
| Investing Activities | |||||
| Capital Expenditures | $0 | -$2.18M | -$15.98M | -$2.63M | -$1M |
| Acquisitions | $0 | $0 | $62K | $0 | $32K |
| Purchases of Investments | $0 | $0 | $0 | $0 | $0 |
| Sales of Investments | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | $1.33M | $0 | $0 | $0 | $0 |
| Net Cash from Investing | $1.33M | -$2.18M | -$15.92M | -$2.63M | -$973K |
| Financing Activities | |||||
| Debt Repaid | $16.16M | -$14.72M | $27K | -$1.76M | -$4.73M |
| Common Stock Issuance | $0 | $157K | $118.58M | $59K | $150K |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | -$245K |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | -$1.16M | -$132K | $561K | -$286K | $150K |
| Net Cash from Financing | -$16.16M | $14.87M | $119.11M | $91.47M | $53.3M |
| Forex Effect | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | -$46.33M | -$62.16M | $36.06M | $57.51M | $35.01M |
| Supplementary Data | |||||
| Operating Cash Flow | -$31.5M | -$74.85M | -$67.13M | -$31.33M | -$17.32M |
| Capital Expenditure | $0 | -$2.18M | -$15.98M | -$2.63M | -$1M |
| Free Cash Flow | -$31.5M | -$77.03M | -$83.12M | -$33.96M | -$18.32M |
| Cash at Beginning | $73.81M | $135.97M | $99.91M | $42.4M | $7.39M |
| Cash at End | $27.47M | $73.81M | $135.97M | $99.91M | $42.4M |